Wilma E. Mesker

Leiden University Medical Center

Papers

1

Total Citations

16

H-Index

1

About

Wilma E. Mesker is a distinguished biomedical researcher whose work centers on cancer diagnostics, biomarker discovery, and the refinement of proteomic profiling techniques. Her major contributions lie in improving the classification of breast cancer through innovative serum workup procedures, as demonstrated in her highly cited 2012 study. This work, which has garnered 16 citations, combined solid-phase extraction methods to enhance the detection of peptide and protein profiles, directly addressing the critical challenge of early-stage breast cancer diagnosis. By optimizing mass spectrometry-based approaches, Mesker has advanced the potential for non-invasive biomarker panels that could significantly improve patient survival rates. Her research exemplifies the intersection of analytical chemistry and clinical oncology, offering practical solutions for translating complex proteomic data into actionable diagnostic tools. Mesker’s careful methodological refinements have not only strengthened the reliability of protein profiling but also provided a foundation for future studies in cancer detection. Her dedication to improving early diagnosis continues to inspire researchers seeking to bridge the gap between laboratory innovation and patient care.

Research Focus

Key Achievements

1
H-Index
1
Papers
16
Total Citations
16
Avg Citations/Paper
🏆 Most Cited Paper
Improved classification of breast cancer peptide and protein profiles by combining two serum workup procedures
16 citations · 2012
📈 Most Prolific Year: 2012 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Leiden University Medical Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago